GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jointown Pharmaceutical Group Co Ltd (SHSE:600998) » Definitions » Total Equity

Jointown Pharmaceutical Group Co (SHSE:600998) Total Equity : ¥30,860 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Jointown Pharmaceutical Group Co Total Equity?

Jointown Pharmaceutical Group Co's total equity for the quarter that ended in Mar. 2024 was ¥30,860 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Jointown Pharmaceutical Group Co Total Equity Historical Data

The historical data trend for Jointown Pharmaceutical Group Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jointown Pharmaceutical Group Co Total Equity Chart

Jointown Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21,967.71 25,610.39 27,072.68 28,685.44 29,477.00

Jointown Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29,201.05 29,111.86 28,303.79 29,477.00 30,860.04

Jointown Pharmaceutical Group Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Jointown Pharmaceutical Group Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=92789.102-63312.104
=29,477

Jointown Pharmaceutical Group Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=97241.244-66381.203
=30,860

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jointown Pharmaceutical Group Co Total Equity Related Terms

Thank you for viewing the detailed overview of Jointown Pharmaceutical Group Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Jointown Pharmaceutical Group Co (SHSE:600998) Business Description

Traded in Other Exchanges
N/A
Address
No 8 Longyang Road, Hanyang District, Wuhan, CHN, 430051
Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and primarily serves medical institutions, wholesale enterprises, and retail pharmacies.
Executives
Liu Yi Chang Director
Ai Hua Director
Wang Qi Bing senior management
Gong Yi Hua Directors, senior managers
Lin Xin Yang Directors, senior managers
Yang Ju Mei senior management
Chen Qi Ming Directors, senior managers
Chen Li Supervisors
Guo Lei senior management
Liu Su Fang senior management
Xu Ming Zhen senior management
Chen Song Bai senior management
Huang Li Hua senior management
Wang Jia Ming senior management
Chen Bo senior management

Jointown Pharmaceutical Group Co (SHSE:600998) Headlines

No Headlines